Cargando…
Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? “Reasons That Reason Itself Does Not Know...”
Autores principales: | Evora, Paulo Roberto B., Gomes, Walter J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357377/ https://www.ncbi.nlm.nih.gov/pubmed/34387969 http://dx.doi.org/10.21470/1678-9741-2021-0957 |
Ejemplares similares
-
Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018) -
Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017) -
Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene
blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015) -
Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017) -
Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report
por: Workum, Jessica D., et al.
Publicado: (2023)